Community-Acquired Pneumonia: Customized Antibiotic Duration Study

We are investigating whether a new strategy for shortening antibiotic treatment is as effective as standard care for hospitalized patients with pneumonia. This study aims to improve patient outcomes while reducing unnecessary antibiotic use.

>2 years ≤5 visits Confirmation phase (III)Cost Reimbursement Partially Remote Standard Medicines Oral InjectionInfectious DiseasesInternal MedicinePulmonology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Cefotaxime Panpharma

Cefotaxime Panpharma is an antibiotic used to treat serious bacterial infections such as pneumonia, sepsis, and meningitis.

Ceftriaxone

Ceftriaxone is an antibiotic used to treat serious bacterial infections such as pneumonia, meningitis, and severe bloodstream infections.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Amoxicillin

Amoxicillin is an antibiotic substance used to treat a range of common bacterial infections such as ear, throat, and urinary tract infections.

Cefotaxime

Cefotaxime is an antibiotic substance used to treat serious bacterial infections by stopping bacteria from growing.

Cefotaxime Sodium

Cefotaxime sodium is an antibiotic substance used to treat serious bacterial infections.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Antadar I.M.

Antadar I.V.

Betasporina

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Assistance Publique Hopitaux De Paris

Maladies infectieuses et tropicales

Angers, France

Centre Hospitalier Universitaire De Bordeaux

Maladies infectieuses

Bordeaux, France

Assistance Publique Hopitaux De Paris

Médecine Interne

Boulogne-Billancourt, France

Sponsor: Assistance Publique Hopitaux De Paris

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.